[
  {
    "index": 1,
    "page": 1,
    "filename": "page1_ignore_figure_001_merged4.png",
    "image_path": "downloads/ketamine-6/page1_ignore_figure_001_merged4.png",
    "context_path": null,
    "width": 1420,
    "height": 234,
    "format": "png",
    "context": "",
    "is_labeled": false,
    "merged_count": 4,
    "original_image_indices": [
      0,
      1,
      2,
      3
    ]
  },
  {
    "index": 2,
    "page": 7,
    "filename": "page7_figure_002_split1.png",
    "image_path": "downloads/ketamine-6/page7_figure_002_split1.png",
    "context_path": "downloads/ketamine-6/page7_figure_002_split1.txt",
    "width": 644,
    "height": 742,
    "format": "png",
    "context": "Figure 1. Characterization of human induced pluripotent stem cell-derived NPCs.\n[From page 8] Figure 2.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 0,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 3,
    "page": 7,
    "filename": "page7_figure_003_split2.png",
    "image_path": "downloads/ketamine-6/page7_figure_003_split2.png",
    "context_path": "downloads/ketamine-6/page7_figure_003_split2.txt",
    "width": 406,
    "height": 293,
    "format": "png",
    "context": "Figure 1. Characterization of human induced pluripotent stem cell-derived NPCs.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 1,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 4,
    "page": 7,
    "filename": "page7_figure_004_split3.png",
    "image_path": "downloads/ketamine-6/page7_figure_004_split3.png",
    "context_path": "downloads/ketamine-6/page7_figure_004_split3.txt",
    "width": 413,
    "height": 287,
    "format": "png",
    "context": "Figure 1. Characterization of human induced pluripotent stem cell-derived NPCs.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 2,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 5,
    "page": 8,
    "filename": "page8_figure_005_split1.png",
    "image_path": "downloads/ketamine-6/page8_figure_005_split1.png",
    "context_path": "downloads/ketamine-6/page8_figure_005_split1.txt",
    "width": 662,
    "height": 513,
    "format": "png",
    "context": "Figure 2. Ketamine increased cell proliferation of human iPSC-derived IMR90 NPCs.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 0,
    "split_from": true,
    "total_splits": 2
  },
  {
    "index": 6,
    "page": 8,
    "filename": "page8_figure_006_split2.png",
    "image_path": "downloads/ketamine-6/page8_figure_006_split2.png",
    "context_path": "downloads/ketamine-6/page8_figure_006_split2.txt",
    "width": 584,
    "height": 375,
    "format": "png",
    "context": "Figure 2. Ketamine increased cell proliferation of human iPSC-derived IMR90 NPCs.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 1,
    "split_from": true,
    "total_splits": 2
  },
  {
    "index": 7,
    "page": 9,
    "filename": "page9_figure_007_split1.png",
    "image_path": "downloads/ketamine-6/page9_figure_007_split1.png",
    "context_path": "downloads/ketamine-6/page9_figure_007_split1.txt",
    "width": 509,
    "height": 359,
    "format": "png",
    "context": "Figure 3.\nConcentration-dependent eﬀects of ketamine on the proliferation in Ro-iPSC NPCs.\nFigure 4. Ketamine induction of proliferation detected by 5-bromo-2′-deoxyuridine (BrdU) staining in\nNPCs.",
    "is_labeled": true,
    "merged_count": 2,
    "split_index": 0,
    "split_from": true,
    "total_splits": 6
  },
  {
    "index": 8,
    "page": 9,
    "filename": "page9_figure_008_split2.png",
    "image_path": "downloads/ketamine-6/page9_figure_008_split2.png",
    "context_path": "downloads/ketamine-6/page9_figure_008_split2.txt",
    "width": 390,
    "height": 365,
    "format": "png",
    "context": "Figure 3.\nConcentration-dependent eﬀects of ketamine on the proliferation in Ro-iPSC NPCs.\nFigure 4. Ketamine induction of proliferation detected by 5-bromo-2′-deoxyuridine (BrdU) staining in\nNPCs.",
    "is_labeled": true,
    "merged_count": 2,
    "split_index": 1,
    "split_from": true,
    "total_splits": 6
  },
  {
    "index": 9,
    "page": 9,
    "filename": "page9_figure_009_split3.png",
    "image_path": "downloads/ketamine-6/page9_figure_009_split3.png",
    "context_path": "downloads/ketamine-6/page9_figure_009_split3.txt",
    "width": 390,
    "height": 365,
    "format": "png",
    "context": "Figure 3.\nConcentration-dependent eﬀects of ketamine on the proliferation in Ro-iPSC NPCs.\nFigure 4. Ketamine induction of proliferation detected by 5-bromo-2′-deoxyuridine (BrdU) staining in\nNPCs.",
    "is_labeled": true,
    "merged_count": 2,
    "split_index": 2,
    "split_from": true,
    "total_splits": 6
  },
  {
    "index": 10,
    "page": 9,
    "filename": "page9_figure_013_split1.png",
    "image_path": "downloads/ketamine-6/page9_figure_013_split1.png",
    "context_path": "downloads/ketamine-6/page9_figure_013_split1.txt",
    "width": 685,
    "height": 370,
    "format": "png",
    "context": "Figure 3.\nConcentration-dependent eﬀects of ketamine on the proliferation in Ro-iPSC NPCs.\nFigure 4. Ketamine induction of proliferation detected by 5-bromo-2′-deoxyuridine (BrdU) staining in\nNPCs.",
    "is_labeled": true,
    "merged_count": 2,
    "split_index": 0,
    "split_from": true,
    "total_splits": 6
  },
  {
    "index": 11,
    "page": 9,
    "filename": "page9_figure_014_split2.png",
    "image_path": "downloads/ketamine-6/page9_figure_014_split2.png",
    "context_path": "downloads/ketamine-6/page9_figure_014_split2.txt",
    "width": 337,
    "height": 344,
    "format": "png",
    "context": "Figure 3.\nConcentration-dependent eﬀects of ketamine on the proliferation in Ro-iPSC NPCs.\nFigure 4. Ketamine induction of proliferation detected by 5-bromo-2′-deoxyuridine (BrdU) staining in\nNPCs.",
    "is_labeled": true,
    "merged_count": 2,
    "split_index": 1,
    "split_from": true,
    "total_splits": 6
  },
  {
    "index": 12,
    "page": 9,
    "filename": "page9_figure_015_split3.png",
    "image_path": "downloads/ketamine-6/page9_figure_015_split3.png",
    "context_path": "downloads/ketamine-6/page9_figure_015_split3.txt",
    "width": 336,
    "height": 342,
    "format": "png",
    "context": "Figure 3.\nConcentration-dependent eﬀects of ketamine on the proliferation in Ro-iPSC NPCs.\nFigure 4. Ketamine induction of proliferation detected by 5-bromo-2′-deoxyuridine (BrdU) staining in\nNPCs.",
    "is_labeled": true,
    "merged_count": 2,
    "split_index": 2,
    "split_from": true,
    "total_splits": 6
  },
  {
    "index": 13,
    "page": 10,
    "filename": "page10_figure_019_split1.png",
    "image_path": "downloads/ketamine-6/page10_figure_019_split1.png",
    "context_path": "downloads/ketamine-6/page10_figure_019_split1.txt",
    "width": 249,
    "height": 395,
    "format": "png",
    "context": "Figure 5. Diﬀerential gene expression in IMR90 NPCs after ketamine treatment.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 0,
    "split_from": true,
    "total_splits": 2
  },
  {
    "index": 14,
    "page": 10,
    "filename": "page10_figure_020_split2.png",
    "image_path": "downloads/ketamine-6/page10_figure_020_split2.png",
    "context_path": "downloads/ketamine-6/page10_figure_020_split2.txt",
    "width": 372,
    "height": 335,
    "format": "png",
    "context": "Figure 5. Diﬀerential gene expression in IMR90 NPCs after ketamine treatment.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 1,
    "split_from": true,
    "total_splits": 2
  },
  {
    "index": 15,
    "page": 10,
    "filename": "page10_figure_021_split1.png",
    "image_path": "downloads/ketamine-6/page10_figure_021_split1.png",
    "context_path": "downloads/ketamine-6/page10_figure_021_split1.txt",
    "width": 258,
    "height": 427,
    "format": "png",
    "context": "Figure 5. Diﬀerential gene expression in IMR90 NPCs after ketamine treatment.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 0,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 16,
    "page": 10,
    "filename": "page10_figure_022_split2.png",
    "image_path": "downloads/ketamine-6/page10_figure_022_split2.png",
    "context_path": "downloads/ketamine-6/page10_figure_022_split2.txt",
    "width": 367,
    "height": 390,
    "format": "png",
    "context": "Figure 5. Diﬀerential gene expression in IMR90 NPCs after ketamine treatment.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 1,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 17,
    "page": 10,
    "filename": "page10_figure_023_split3.png",
    "image_path": "downloads/ketamine-6/page10_figure_023_split3.png",
    "context_path": "downloads/ketamine-6/page10_figure_023_split3.txt",
    "width": 369,
    "height": 390,
    "format": "png",
    "context": "Figure 5. Diﬀerential gene expression in IMR90 NPCs after ketamine treatment.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 2,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 18,
    "page": 11,
    "filename": "page11_figure_024.png",
    "image_path": "downloads/ketamine-6/page11_figure_024.png",
    "context_path": "downloads/ketamine-6/page11_figure_024.txt",
    "width": 1345,
    "height": 413,
    "format": "png",
    "context": "Figure 6. NPC cell proliferation is reduced after IGF2 knockdown.",
    "is_labeled": true,
    "merged_count": 1
  },
  {
    "index": 19,
    "page": 11,
    "filename": "page11_figure_025_split1.png",
    "image_path": "downloads/ketamine-6/page11_figure_025_split1.png",
    "context_path": "downloads/ketamine-6/page11_figure_025_split1.txt",
    "width": 425,
    "height": 404,
    "format": "png",
    "context": "Figure 6. NPC cell proliferation is reduced after IGF2 knockdown.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 0,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 20,
    "page": 11,
    "filename": "page11_figure_026_split2.png",
    "image_path": "downloads/ketamine-6/page11_figure_026_split2.png",
    "context_path": "downloads/ketamine-6/page11_figure_026_split2.txt",
    "width": 417,
    "height": 338,
    "format": "png",
    "context": "Figure 6. NPC cell proliferation is reduced after IGF2 knockdown.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 1,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 21,
    "page": 11,
    "filename": "page11_ignore_figure_027_split3.png",
    "image_path": "downloads/ketamine-6/page11_ignore_figure_027_split3.png",
    "context_path": null,
    "width": 270,
    "height": 129,
    "format": "png",
    "context": "",
    "is_labeled": false,
    "merged_count": 1,
    "split_index": 2,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 22,
    "page": 12,
    "filename": "page12_figure_028_split1.png",
    "image_path": "downloads/ketamine-6/page12_figure_028_split1.png",
    "context_path": "downloads/ketamine-6/page12_figure_028_split1.txt",
    "width": 433,
    "height": 469,
    "format": "png",
    "context": "Figure 7. cAMP-IGF2 signaling is involved in ketamine’s proliferative eﬀect.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 0,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 23,
    "page": 12,
    "filename": "page12_figure_029_split2.png",
    "image_path": "downloads/ketamine-6/page12_figure_029_split2.png",
    "context_path": "downloads/ketamine-6/page12_figure_029_split2.txt",
    "width": 388,
    "height": 417,
    "format": "png",
    "context": "Figure 7. cAMP-IGF2 signaling is involved in ketamine’s proliferative eﬀect.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 1,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 24,
    "page": 12,
    "filename": "page12_figure_030_split3.png",
    "image_path": "downloads/ketamine-6/page12_figure_030_split3.png",
    "context_path": "downloads/ketamine-6/page12_figure_030_split3.txt",
    "width": 431,
    "height": 392,
    "format": "png",
    "context": "Figure 7. cAMP-IGF2 signaling is involved in ketamine’s proliferative eﬀect.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 2,
    "split_from": true,
    "total_splits": 3
  },
  {
    "index": 25,
    "page": 13,
    "filename": "page13_figure_031_split1.png",
    "image_path": "downloads/ketamine-6/page13_figure_031_split1.png",
    "context_path": "downloads/ketamine-6/page13_figure_031_split1.txt",
    "width": 561,
    "height": 753,
    "format": "png",
    "context": "Figure 8.\nKetamine increased extracellular signal-regulated protein kinases 1 and 2 (ERK1/2)\nphosphorylation in mice 24 h after administration (A) Experimental timeline: male C67BL/6 mice were\ninjected intraperitoneal (i.\nFigure 9. Hypothesis of the molecular mechanism of action in human NPCs induced by ketamine.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 0,
    "split_from": true,
    "total_splits": 2
  },
  {
    "index": 26,
    "page": 13,
    "filename": "page13_figure_032_split2.png",
    "image_path": "downloads/ketamine-6/page13_figure_032_split2.png",
    "context_path": "downloads/ketamine-6/page13_figure_032_split2.txt",
    "width": 539,
    "height": 547,
    "format": "png",
    "context": "Figure 8.\nKetamine increased extracellular signal-regulated protein kinases 1 and 2 (ERK1/2)\nphosphorylation in mice 24 h after administration (A) Experimental timeline: male C67BL/6 mice were\ninjected intraperitoneal (i.\nFigure 9. Hypothesis of the molecular mechanism of action in human NPCs induced by ketamine.",
    "is_labeled": true,
    "merged_count": 1,
    "split_index": 1,
    "split_from": true,
    "total_splits": 2
  },
  {
    "index": 27,
    "page": 13,
    "filename": "page13_figure_033.jpeg",
    "image_path": "downloads/ketamine-6/page13_figure_033.jpeg",
    "context_path": "downloads/ketamine-6/page13_figure_033.txt",
    "width": 1350,
    "height": 730,
    "format": "jpeg",
    "context": "Figure 8.\nKetamine increased extracellular signal-regulated protein kinases 1 and 2 (ERK1/2)\nphosphorylation in mice 24 h after administration (A) Experimental timeline: male C67BL/6 mice were\ninjected intraperitoneal (i.\nFigure 9. Hypothesis of the molecular mechanism of action in human NPCs induced by ketamine.",
    "is_labeled": true,
    "merged_count": 1
  },
  {
    "index": 28,
    "page": 18,
    "filename": "page18_ignore_figure_037.png",
    "image_path": "downloads/ketamine-6/page18_ignore_figure_037.png",
    "context_path": null,
    "width": 500,
    "height": 175,
    "format": "png",
    "context": "",
    "is_labeled": false,
    "merged_count": 1
  }
]